A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus

Clinical trial NCT06943937 · RECRUITING

Trial details

NCT number: NCT06943937
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lupus Nephritis (LN)Immune Thrombocytopenia (ITP)

Start date: 2025-04-16
Primary completion: 2026-04-25
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.